SGAM
APYX icon

Smith Group Asset Management’s Apyx Medical APYX Stock Holding History

Smith Group Asset Management’s Portfolio APYX Stock Details APYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-16,200
Closed -$137K – 360
2019
Q4 		$137K Hold
16,200
– – 0.01% 225
2019
Q3 		$110K Hold
16,200
– – ﹤0.01% 236
2019
Q2 		$109K Hold
16,200
– – ﹤0.01% 232
2019
Q1 		$102K Sell
16,200
-970
-6% -$7.5K ﹤0.01% 255
2018
Q4 		$111K Buy
+17,170
New +$104K ﹤0.01% 278

Other funds holding APYX

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $246M AUM 130.69% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PVI
Pura Vida Investments New York $37M AUM 63.54% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
HKAM
Horizon Kinetics Asset Management New York $8.82B AUM 23.05% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TFCM
Taylor Frigon Capital Management Scottsdale, Arizona $214M AUM 47.29% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Smith Group Asset Management's APYX Position: Q1 2020 in Review

Smith Group Asset Management sold out of Apyx Medical (APYX) in Q1 2020, closing a stake of 16,200 shares — an estimated $137K sold.

Smith Group Asset Management first reported a position in APYX in Q4 2018 and held it in 5 quarters. The position peaked at $137K in Q4 2019. 67 funds tracked by Wall St. Rank hold APYX as of Q1 2020.

  • Smith Group Asset Management reported no remaining Apyx Medical position as of Q1 2020 after selling out during the quarter.
  • Smith Group Asset Management sold 16,200 Apyx Medical shares in Q1 2020, an estimated $137K.
  • Smith Group Asset Management first reported a position in Apyx Medical in Q4 2018 and held it in 5 quarters.
  • Smith Group Asset Management's Apyx Medical position peaked at $137K in Q4 2019.
  • 67 funds tracked by Wall St. Rank held Apyx Medical as of Q1 2020.

Based on Smith Group Asset Management's 13F filing for Q1 2020, filed 12 May 2020.